OpenLegislation

Division NotesF1

United Kingdom

Original text. Later amendments are not shown.

  1. 1Division 1
  2. 2Division 2
  3. 3Division 3
  4. 4Division 4
  5. 5Division 5
  6. 6Division 6
  7. 7Division 7
  8. 8Division 8
  9. 9Division 9
  10. 10Division 10
  11. 11Boxes 12a, 12b: Enter the 8 digit CN code of the scheduled substance as stated in the Annex of Regulation (EC) No 111/2005.
  12. 12Box 16:
  13. 13...

Annotations

Textual amendments

F1

Regulation revoked (N.I.) (29.6.2026) by The Controlled Drugs (Drug Precursors) (Amendment and Revocation) Regulations 2026 (S.I. 2026/607), reg. 1(1), Sch.

Notes on Annex IV

Textual amendments

F2

Annex 4 Form heading: words “UNITED KINGDOM” substituted for “EUROPEAN UNION” (31.12.2020) by The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(11)(a)(i); 2020 c. 1, Sch. 5 para. 1(1)

F3

Annex 4 Form box 9: words “United Kingdom” substituted for “customs territory of the Union” (31.12.2020) by The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(11)(a)(ii); 2020 c. 1, Sch. 5 para. 1(1)

F4

Annex 4 Form heading: words “European Union or Great Britain” substituted for “UNITED KINGDOM” (29.6.2026) by The Controlled Drugs (Drug Precursors) (Amendment and Revocation) Regulations 2026 (S.I. 2026/607), regs. 1(1), 8(8)(a)(i)

F5

Annex 4 Form box 9: words “Great Britain/the customs territory of the Union” substituted for “the United Kingdom” (29.6.2026) by The Controlled Drugs (Drug Precursors) (Amendment and Revocation) Regulations 2026 (S.I. 2026/607), regs. 1(1), 8(8)(a)(ii)